National Bleeding Disorders Foundation

National Bleeding Disorders Foundation company information, Employees & Contact Information

The National Bleeding Disorders Foundation is dedicated to finding better treatments and cures for inheritable blood and bleeding disorders and to preventing the complications of these disorders through education, advocacy and research. Its programs and initiatives are made possible through the generosity of individuals, corporations and foundations as well as through a cooperative agreement with the Centers for Disease Control and Prevention (CDC).
Looking for a particular National Bleeding Disorders Foundation employee's phone or email?

National Bleeding Disorders Foundation Questions

News

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A - The New England Journal of Medicine

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A The New England Journal of Medicine

Nano‐evidence for joint microbleeds in hemophilia patients - ScienceDirect.com

Nano‐evidence for joint microbleeds in hemophilia patients ScienceDirect.com

Supporting the Hemophilia Community - Pfizer

Supporting the Hemophilia Community Pfizer

International recommendations on the diagnosis and treatment of acquired hemophilia A - Haematologica

International recommendations on the diagnosis and treatment of acquired hemophilia A Haematologica

Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus - Frontiers

Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus Frontiers

The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation - Business Wire

The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation Business Wire

Bleeding Disorders Awareness Month puts spotlight on education |... - Hemophilia News Today

Bleeding Disorders Awareness Month puts spotlight on education |... Hemophilia News Today

Oral Anticoagulation and Factor VIII Replacement Therapy in Patients With Hemophilia Undergoing Pulsed-Field or Radiofrequency Catheter Ablation for Atrial Fibrillation - American Heart Association Journals

Oral Anticoagulation and Factor VIII Replacement Therapy in Patients With Hemophilia Undergoing Pulsed-Field or Radiofrequency Catheter Ablation for Atrial Fibrillation American Heart Association Journals

Breakthroughs in Gene Therapy for Hemophilia - ashpublications.org

Breakthroughs in Gene Therapy for Hemophilia ashpublications.org

The Implication of New Developments in Hemophilia Treatment on Its Laboratory Evaluation - Cureus

The Implication of New Developments in Hemophilia Treatment on Its Laboratory Evaluation Cureus

Rare within rare: Women with haemophilia - Roche

Rare within rare: Women with haemophilia Roche

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia - EMBO Press

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia EMBO Press

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A - The New England Journal of Medicine

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A The New England Journal of Medicine

Between Scylla and Charybdis: thrombosis in children with hemophilia - Frontiers

Between Scylla and Charybdis: thrombosis in children with hemophilia Frontiers

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B The New England Journal of Medicine

Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A - Frontiers

Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A Frontiers

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors - The New England Journal of Medicine

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors The New England Journal of Medicine

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A - The New England Journal of Medicine

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A The New England Journal of Medicine

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A - The New England Journal of Medicine

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A The New England Journal of Medicine

Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - The New England Journal of Medicine

Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B The New England Journal of Medicine

Emicizumab Prophylaxis in Hemophilia A with Inhibitors - The New England Journal of Medicine

Emicizumab Prophylaxis in Hemophilia A with Inhibitors The New England Journal of Medicine

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A - The New England Journal of Medicine

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A The New England Journal of Medicine

B cell–activating factor modulates the factor VIII immune response in hemophilia A - JCI.org

B cell–activating factor modulates the factor VIII immune response in hemophilia A JCI.org

AAV5–Factor VIII Gene Transfer in Severe Hemophilia A - The New England Journal of Medicine

AAV5–Factor VIII Gene Transfer in Severe Hemophilia A The New England Journal of Medicine

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy - The New England Journal of Medicine

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy The New England Journal of Medicine

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors - The New England Journal of Medicine

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors The New England Journal of Medicine

Case Closed: Famous Royals Suffered From Hemophilia - Science | AAAS

Case Closed: Famous Royals Suffered From Hemophilia Science | AAAS

Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits - Frontiers

Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits Frontiers

Real-world evidence on Kovaltry (81-8973) in children with moderate or severe hemophilia A in Europe: a nested cohort analysis - Orphanet Journal of Rare Diseases

Real-world evidence on Kovaltry (81-8973) in children with moderate or severe hemophilia A in Europe: a nested cohort analysis Orphanet Journal of Rare Diseases

A Machine Learning Framework Predicts the Clinical Severity of Hemophilia B Caused by Point-Mutations - Frontiers

A Machine Learning Framework Predicts the Clinical Severity of Hemophilia B Caused by Point-Mutations Frontiers

The hemophilia quality of life scale: a systematic review - Frontiers

The hemophilia quality of life scale: a systematic review Frontiers

HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdataset - Frontiers

HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdataset Frontiers

The National Hemophilia Foundation Launches the Red Tie Challenge™ - PR Newswire

The National Hemophilia Foundation Launches the Red Tie Challenge™ PR Newswire

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy - Science | AAAS

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy Science | AAAS

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B - The New England Journal of Medicine

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B The New England Journal of Medicine

F8 gene inversion and duplication cause no obvious hemophilia A phenotype - Frontiers

F8 gene inversion and duplication cause no obvious hemophilia A phenotype Frontiers

Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs - JCI.org

Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs JCI.org

Gender equity in hemophilia: need for healthcare, familial, and societal advocacy - Frontiers

Gender equity in hemophilia: need for healthcare, familial, and societal advocacy Frontiers

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A - The New England Journal of Medicine

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A The New England Journal of Medicine

Full article: Burden of illness: direct and indirect costs among persons with hemophilia A in the United States - Taylor & Francis Online

Full article: Burden of illness: direct and indirect costs among persons with hemophilia A in the United States Taylor & Francis Online

Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII - Nature

Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII Nature

Novo Nordisk Marks World Hemophilia Day by Raising Awareness of Bleeding Disorders in the Community and Beyond - PR Newswire

Novo Nordisk Marks World Hemophilia Day by Raising Awareness of Bleeding Disorders in the Community and Beyond PR Newswire

Gene Therapy Research Offers Transformative Possibilities for People Living With Hemophilia B - Future of Personal Health -

Gene Therapy Research Offers Transformative Possibilities for People Living With Hemophilia B Future of Personal Health -

My top social media picks for the bleeding disorders community - Hemophilia News Today

My top social media picks for the bleeding disorders community Hemophilia News Today

Neonatal Hemophilia A - Consultant360

Neonatal Hemophilia A Consultant360

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B - The New England Journal of Medicine

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B The New England Journal of Medicine

Living with Hemophilia: Nick’s Story - CHOC - Children's Health Hub

Living with Hemophilia: Nick’s Story CHOC - Children's Health Hub

Center Treats Children With Bleeding Disorders - UKNow

Center Treats Children With Bleeding Disorders UKNow

Candice (Wyse) Dunlop Obituary September 5, 2021 - French Funerals & Cremations

Candice (Wyse) Dunlop Obituary September 5, 2021 French Funerals & Cremations

Rita Teresa Callaghan Obituary April 9, 2024 - Donohue Funeral Home

Rita Teresa Callaghan Obituary April 9, 2024 Donohue Funeral Home

Bayer Receives FDA Approval for Jivi®, New Hemophilia A Treatment With Step-Wise Prophylaxis Dosing Regimen - PR Newswire

Bayer Receives FDA Approval for Jivi®, New Hemophilia A Treatment With Step-Wise Prophylaxis Dosing Regimen PR Newswire

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia - The New England Journal of Medicine

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia The New England Journal of Medicine

Inhibitors of Factor VIII in Black Patients with Hemophilia - The New England Journal of Medicine

Inhibitors of Factor VIII in Black Patients with Hemophilia The New England Journal of Medicine

Phyllis Baker Obituary - Evansville, IN - Dignity Memorial

Phyllis Baker Obituary - Evansville, IN Dignity Memorial

Donald Goldman Obituary - Livingston, NJ - Dignity Memorial

Donald Goldman Obituary - Livingston, NJ Dignity Memorial

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A - Haematologica

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A Haematologica

Richard Solomon Obituary - Canton, MA - Dignity Memorial

Richard Solomon Obituary - Canton, MA Dignity Memorial

Tackling Hemophilia in Kenya - The Borgen Project

Tackling Hemophilia in Kenya The Borgen Project

Shellene Haza Obituary - Woodstock, GA - Dignity Memorial

Shellene Haza Obituary - Woodstock, GA Dignity Memorial

Flagler Beach man helps launch nonprofit to end hemophilia - Observer Local News

Flagler Beach man helps launch nonprofit to end hemophilia Observer Local News

Steven Rieben Obituary (1983 - 2015) - Sauquoit, NY - The Observer-Dispatch - Legacy obituary

Steven Rieben Obituary (1983 - 2015) - Sauquoit, NY - The Observer-Dispatch Legacy obituary

Jeanine Robinson Obituary (1936 - 2021) - Salt Lake City, UT - Deseret News - Legacy obituary

Jeanine Robinson Obituary (1936 - 2021) - Salt Lake City, UT - Deseret News Legacy obituary

Patricia Dorr Obituary - Washingtonville, NY - Dignity Memorial

Patricia Dorr Obituary - Washingtonville, NY Dignity Memorial

Roberta Foss-Morgan Obituary (2023) - Mt Holly, NJ - The Press of Atlantic City - Legacy obituary

Roberta Foss-Morgan Obituary (2023) - Mt Holly, NJ - The Press of Atlantic City Legacy obituary

Beau Terle Obituary - Woodstock, GA - Dignity Memorial

Beau Terle Obituary - Woodstock, GA Dignity Memorial

Christopher Carr Obituary (2022) - Wallingford, CT - New Haven Register - Legacy obituary

Christopher Carr Obituary (2022) - Wallingford, CT - New Haven Register Legacy obituary

RICHARD SOLOMON Obituary (2023) - Wayland, MA - Boston Globe - Legacy obituary

RICHARD SOLOMON Obituary (2023) - Wayland, MA - Boston Globe Legacy obituary

Kirsten Scillia Obituary (2018) - West Haven, CT - New Haven Register - Legacy obituary

Kirsten Scillia Obituary (2018) - West Haven, CT - New Haven Register Legacy obituary

MICHAEL KOEPKE Obituary (2018) - MUNDELEIN, IL - Daily Herald - Legacy obituary

MICHAEL KOEPKE Obituary (2018) - MUNDELEIN, IL - Daily Herald Legacy obituary

Ahwatukee family faces challenges of hemophilia: Walk this weekend to help raise funds, awareness of bleeding disorder - Ahwatukee Foothills News

Ahwatukee family faces challenges of hemophilia: Walk this weekend to help raise funds, awareness of bleeding disorder Ahwatukee Foothills News

Laugh until you scream with Alex Borstein from ‘Family Guy’ - Metro US

Laugh until you scream with Alex Borstein from ‘Family Guy’ Metro US

Top National Bleeding Disorders Foundation Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant